A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: The aim of this study was to determine whether the functional chemokine receptor 5 delta32 (CCR5-Δ32) polymorphism is associated with multiple sclerosis (MS) susceptibility. Methods: Meta-analysis was conducted to determine the association between the CCR5-Δ32 polymorphism and overall incidence of MS as well frequency of relapsing-remitting (RR), primary progressive (PP), and secondary progressive (SP) MS subtypes. Results: In total, 3869 subjects from eight studies (MS 1666, controls 2203) were considered for meta-analysis. Meta-analysis showed no association between MS and the CCR5-Δ32 allele polymorphism (OR = 1.102, 95% CI = 0.830-1.462, p = 0.502) with a mean frequency of 11.3% in MS patients and 10.4% in controls. Stratification by ethnicity indicated no association between the CCR5-Δ32 allele and MS in Europeans (OR = 0.958, 95% CI = 0.811-1.132, p = 0.618). Meta-analysis by the disease subtype showed no association between RR-MS and the CCR5-Δ32 allele (OR = 1.234, 95% CI = 0.908-1.677, p = 0.178). In addition, no association was found between the CCR5-Δ32 polymorphism and PP or SP-MS. Conclusions: Meta-analysis of 3869 subjects indicates a lack of association between the CCR5-Δ32 polymorphism and MS risk in Europeans.

Original languageEnglish
Pages (from-to)299-311
Number of pages13
JournalImmunological Investigations
Volume43
Issue number4
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Chemokine Receptors
Multiple Sclerosis
Meta-Analysis
Chronic Progressive Multiple Sclerosis
Alleles
Relapsing-Remitting Multiple Sclerosis
Incidence

Keywords

  • CCR5-Δ32 polymorphism
  • Meta-analysis
  • Multiple sclerosis

ASJC Scopus subject areas

  • Immunology

Cite this

@article{f41e2155b9514156a5bce45e7e4254ef,
title = "A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility",
abstract = "Objective: The aim of this study was to determine whether the functional chemokine receptor 5 delta32 (CCR5-Δ32) polymorphism is associated with multiple sclerosis (MS) susceptibility. Methods: Meta-analysis was conducted to determine the association between the CCR5-Δ32 polymorphism and overall incidence of MS as well frequency of relapsing-remitting (RR), primary progressive (PP), and secondary progressive (SP) MS subtypes. Results: In total, 3869 subjects from eight studies (MS 1666, controls 2203) were considered for meta-analysis. Meta-analysis showed no association between MS and the CCR5-Δ32 allele polymorphism (OR = 1.102, 95{\%} CI = 0.830-1.462, p = 0.502) with a mean frequency of 11.3{\%} in MS patients and 10.4{\%} in controls. Stratification by ethnicity indicated no association between the CCR5-Δ32 allele and MS in Europeans (OR = 0.958, 95{\%} CI = 0.811-1.132, p = 0.618). Meta-analysis by the disease subtype showed no association between RR-MS and the CCR5-Δ32 allele (OR = 1.234, 95{\%} CI = 0.908-1.677, p = 0.178). In addition, no association was found between the CCR5-Δ32 polymorphism and PP or SP-MS. Conclusions: Meta-analysis of 3869 subjects indicates a lack of association between the CCR5-Δ32 polymorphism and MS risk in Europeans.",
keywords = "CCR5-Δ32 polymorphism, Meta-analysis, Multiple sclerosis",
author = "Song, {Gwan Gyu} and Lee, {Young Ho}",
year = "2014",
month = "1",
day = "1",
doi = "10.3109/08820139.2013.845204",
language = "English",
volume = "43",
pages = "299--311",
journal = "Immunological Investigations",
issn = "0882-0139",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility

AU - Song, Gwan Gyu

AU - Lee, Young Ho

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objective: The aim of this study was to determine whether the functional chemokine receptor 5 delta32 (CCR5-Δ32) polymorphism is associated with multiple sclerosis (MS) susceptibility. Methods: Meta-analysis was conducted to determine the association between the CCR5-Δ32 polymorphism and overall incidence of MS as well frequency of relapsing-remitting (RR), primary progressive (PP), and secondary progressive (SP) MS subtypes. Results: In total, 3869 subjects from eight studies (MS 1666, controls 2203) were considered for meta-analysis. Meta-analysis showed no association between MS and the CCR5-Δ32 allele polymorphism (OR = 1.102, 95% CI = 0.830-1.462, p = 0.502) with a mean frequency of 11.3% in MS patients and 10.4% in controls. Stratification by ethnicity indicated no association between the CCR5-Δ32 allele and MS in Europeans (OR = 0.958, 95% CI = 0.811-1.132, p = 0.618). Meta-analysis by the disease subtype showed no association between RR-MS and the CCR5-Δ32 allele (OR = 1.234, 95% CI = 0.908-1.677, p = 0.178). In addition, no association was found between the CCR5-Δ32 polymorphism and PP or SP-MS. Conclusions: Meta-analysis of 3869 subjects indicates a lack of association between the CCR5-Δ32 polymorphism and MS risk in Europeans.

AB - Objective: The aim of this study was to determine whether the functional chemokine receptor 5 delta32 (CCR5-Δ32) polymorphism is associated with multiple sclerosis (MS) susceptibility. Methods: Meta-analysis was conducted to determine the association between the CCR5-Δ32 polymorphism and overall incidence of MS as well frequency of relapsing-remitting (RR), primary progressive (PP), and secondary progressive (SP) MS subtypes. Results: In total, 3869 subjects from eight studies (MS 1666, controls 2203) were considered for meta-analysis. Meta-analysis showed no association between MS and the CCR5-Δ32 allele polymorphism (OR = 1.102, 95% CI = 0.830-1.462, p = 0.502) with a mean frequency of 11.3% in MS patients and 10.4% in controls. Stratification by ethnicity indicated no association between the CCR5-Δ32 allele and MS in Europeans (OR = 0.958, 95% CI = 0.811-1.132, p = 0.618). Meta-analysis by the disease subtype showed no association between RR-MS and the CCR5-Δ32 allele (OR = 1.234, 95% CI = 0.908-1.677, p = 0.178). In addition, no association was found between the CCR5-Δ32 polymorphism and PP or SP-MS. Conclusions: Meta-analysis of 3869 subjects indicates a lack of association between the CCR5-Δ32 polymorphism and MS risk in Europeans.

KW - CCR5-Δ32 polymorphism

KW - Meta-analysis

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=84897978799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897978799&partnerID=8YFLogxK

U2 - 10.3109/08820139.2013.845204

DO - 10.3109/08820139.2013.845204

M3 - Article

VL - 43

SP - 299

EP - 311

JO - Immunological Investigations

JF - Immunological Investigations

SN - 0882-0139

IS - 4

ER -